Search Results 131-140 of 16395 for infliximab
At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] at Baseline and Weeks 2, and 6);; At least one 4-week induction regimen of ...
... infliximab (Remicade), rituximab (Rituxan), sarilumab (Kevzara) and tocilizumab (Actemra). Biologic DMARDs most often work best when used with a ...
Medications in this category include infliximab (Remicade) and etanercept (Enbrel). Work closely with a rheumatologist to determine the treatment approach ...
Infliximab; Influenza Virus Vaccine, Live; Rotavirus Vaccine, Live; SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine ...
Infliximab (intravenous route). Renflexis. Also known as. Infliximab-abda (intravenous route). Reno-30. Also known as. Diatrizoate (intravenous route). Reno-60.
... infliximab; Intolerance to at least 2 anti-TNF-alpha biologic ... Has received infliximab, infliximab biosimilar, or golimumab intravenous (IV) ...
Within the United States, four anti-TNF agents are currently approved for the treatment of IBD — infliximab, adalimumab, certolizumab pegol and golimumab.
It's less effective than adalimumab and infliximab. It might cause upset stomach, loss of appetite and fatigue. People taking methotrexate long-term need ...
Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!